The fact that, of the approximately 600,000 plant species existing on the earth, only some 5 % have been specifically investigated chemically or pharmacologi cally, is a challenge to chemists spezializing in na tural substances and to pharmacologists. In view of the limited number of research capacities and the ever diminishing financial means, this challenge can only be met if, together with an improvement and refinement of methods of analysis, medicinal plant research is carried out on a broader interdisciplinary basis, with comparable, scientifically recognized screening methods, and if it is better coordinated, with greater use of modern documentation means. It is thus necessary in the future to concentrate specifically on projects leading to the development of new medicinal prepara tions. The plenary lectures hold in the present symposium of the 1st International Congress for Research on Medi cinal Plants reflect these efforts and tendencies. At the same time they provide a survey of some of the fields of medicinal plant research which are at present most actual and most intensively researched. They range from plant screening, isolation and structure eluci dation of new principles, to the therapeutical opti mization of a natural product. The lectures given at this congress show clearly the necessity, in addition to national phytochemical so cieties, for a central international organisation, in which all active medicinal plant researchers in the world are included. Their aim should be to provide the impulse for more optimal, rational research, aimed at the solution of specific projects.
Natural products have played an important role throughout the world in treating and preventing human diseases. Natural product medicines have come from various materials including terrestrial plants, terrestrial microorganisms, organisms etc. Historical experiences with plants as therapeutic tools have helped to introduce single chemical entries in modern medicine. About 40% of the drugs used are derived from natural sources. Most are pure substances which are isolated from various organisms & used directly or after chemical modification. Natural products will continue to be important in three areas of drug discovery: as targets for production by biotechnology as a source of new lead compounds of novel chemical structure and as the active ingredients of useful treatments derived from traditional systems. Biotechnology will contribute more new natural products for medicinal use. Plants provide a fertile source of natural products many of which are clinically important medicinal agents. Natural products have traditionally provided most of the drugs in use. Despite the achievements of synthetic chemistry and the advances towards rational drug design, natural products continue to be essential in providing medicinal compounds and as starting points for the development of synthetic analogues. With the increasing power of screening programs and the increasing interest in the reservoir of untested natural products, many future drug developments will be based, at least in part, on natural products. The major contents of the book are plant products produced in cell culture , application of genetic engineering to the production of pharmaceuticals , anti transpirants and plant growth regulators based , the potential and the problems of marine natural products, marine sterols, plants as a source of anti-inflammatory substances, anti hepatotoxic principles in oriental medicinal plants, immune stimulants of fungi and higher plants, amanita muscaria in medicinal chemistry, ergot alkaloids and their derivatives in medicinal chemistry and therapy, development of drugs from cannabinoids, etc. This book contains development of new drugs from plants, work on some Thai medicinal plants, plant growth based on Jasmonates, marine sterols, bleomycin and its derivatives, drugs from cannabinoids, bioactive compounds from nature, fungi and higher plants, biological active compounds from British Marine, microbial phytotoxins as herbicides and many more. This book will be very helpful to its readers, upcoming entrepreneurs, scientists, existing industries, technical institutions, druggist etc. TAGS Drugs from Natural Sources, Plants as Source of Drugs, Plant Based Drugs and Medicines, Drugs from Natural Products, Drugs from Plants, Natural Products, Natural Products in Drugs, Sources of Drugs, Drug from Medicinal Plants, Bioactive Compounds from Natural Sources, Biologically Active Compounds from British Marine Algae, Drugs from Natural Bio Sources, Natural Products as Sources of Drugs, Medicinal Natural Products, Plant Based Natural Products, Drugs of Natural Origin, Drugs from Cannabinoids, Plant Products Produced in Cell Culture, Herbicidal Compounds, Microbes and Microbial Phytotoxins as Herbicides, Chinese Traditional Medicine, Thai Medicinal Plants, Ompounds Derived from Hormones, Indigenous Medicinal Plants, Plants as Source of Anti-Inflammatory Substances, Bleomycin and its Derivatives, Antineoplastic Structure-Activity, Oriental Medicinal Plants, Immunostimulants of Fungi and Higher Plants, Acacia, Abrus Precatorius Linn, Babul, Acacia Catechu Willd, Chyranthes Aspera Linn, Adhatoda Vasica Nees, Allium Sativum Linn, Aloe Barbadensis Mill, Argemone Mexicana Linn, Neem, Asparagus Racemosus Willd, Azadirachta Indica, Boerhaavia Chinensis Aschers & Schweinf, Boswellia Serrata Roxb, Butea Frondosa, Butea Monosperma Taub, Cassia Fistula Linn, Cassia Tora Linn, Carica Papaya Linn, Evolvulus Alsinoides, Clitoria Ternatea Linn, Clerodendron Phlomidis Linn, Cuscuta Reflexa Roxbi, Glycyrrhiza Glabra, Gmelina Arborea Roxb, Morinda Tinctoria Roxb, Melia Azedarach Linn, Pterocarpus Santalinus, Raphanus Sativces, Viola Odorata, Ashawgandha, Withania Somnifera, Muli, Lal Chandan, Raktachandan, Bakain, Bakaanaanimb, Aakaashvalli, Shankhahuli, Talmuli, Chibud, Sweet Melon, Aparajit, Arni, Quall Grass, Sufaid Murgha, Lasun, Ghungehi, Khair, Adulsa, Arusha, NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Startup, Business Guidance, Business Guidance to Clients, Startup Ideas, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Best Small and Cottage Scale Industries, Startup India, Stand Up India, Small Scale Industries, New Small Scale Ideas for Thai Medicinal Plants, Natural Products in Drugs Business Ideas You Can Start on Your Own, Guide to Starting and Operating Small Business, Business Ideas for Drugs From Natural Sources, How to Start Drugs from Natural Sources Business, Start Your Own Drug from Medicinal Plants Business, Natural Drugs Business Plan, Business Plan for Natural Drugs, Small Scale Industries in India, Drugs from Cannabinoids Based Small Business Ideas in India, Small Scale Industry You Can Start on Your Own, Business Plan for Small Scale Industries, Profitable Small Scale Manufacturing, How to Start Small Business in India, Free Manufacturing Business Plans, Small and Medium Scale Manufacturing, Profitable Small Business Industries Ideas, Business Ideas for Startup
Medicinal plants and their derived products remain as an indispensable source of bioactive molecules that serve as either drug candidates or lead compounds for drug design and discovery. There are several advantages for plant-derived therapeutics including wide availability, diverse pharmacological actions and a generally good profile of safety and tolerability. Over the recent years, there have been numerous reports from clinical studies testifying to the efficacy and safety of medicinal plants and phytochemicals in ameliorating several human diseases. A plethora of basic studies has also unravelled molecular mechanisms underlying the health benefits of herbal medicines. Nevertheless, issues such as identification of bioactive ingredients, standardization of the products and drug interactions remain to be further studied. In this book, we aim to put together several chapters on the medicinal properties and pharmacological action of medicinal plants, plant species and phytochemicals. The goal is to present a comprehensive collection on most of the therapeutic aspects of plant-derived natural products and molecular mechanisms thereof.
Plant extracts are widely used for therapeutic purposes. The vegetal origin of these products satisfies people’s desire to cure themselves with natural drugs; this aspect, together with effectiveness and regulatory opportunities, is the base of the broad modern use of medicinal plants. Traditional uses and novel biological effects allow the availability of an extraordinarily high number of different compounds with formidable therapeutic potential. Nevertheless, pitfalls are hidden behind poor pharmacological and toxicological knowledge of plant extracts, nonstandardized methods of extraction, and undefined and nonrepeatable qualitative and quantitative composition. In this context, novel experimental studies on plant products and appreciated and are necessary to reinforce the scientific soundness of phytotherapy. This book aims to respond to this medical need comprehensively highlighting the newest discoveries in vegetal resources with an emphasis on pharmacological activity.
Botanicals, which have been part of human food and medicine for thousands of years, are perceived as being safer than synthetic pharmaceuticals. The global botanical drug market was expected to reach $26.6 billion by 2017. In terms of FDA regulations, botanical drugs are no different from non-botanical products, having to meet the safety and effectiveness standards of a new drug in accordance. This book comprises a complete start-to-end process from drug-idea conception, to drug development process.
